Effect of Endometrial Ablation by Thermal Balloon vs. Hysteroscopy Ablation on Amenorrhea Rates in Patients with Abnormal Uterine Bleeding: A Randomized Clinical Trial.

Ablation Technique Dysfunctional uterine bleeding Endometrial Hysteroscopy

Journal

International journal of fertility & sterility
ISSN: 2008-076X
Titre abrégé: Int J Fertil Steril
Pays: Iran
ID NLM: 101487941

Informations de publication

Date de publication:
01 Feb 2023
Historique:
received: 14 03 2022
entrez: 12 3 2023
pubmed: 13 3 2023
medline: 13 3 2023
Statut: epublish

Résumé

Abnormal uterine bleeding (AUB) that is any irregularity in menstrual cycles causes women to refer to clinics. This study aimed to compare the efficacy, safety, and complications of endometrial ablation by the thermal balloon (Cavaterm) method with the hysteroscopy loop resection method in the treatment of AUB. The present study is an open-label, randomized clinical trial that was performed in the two hospitals, Shahid Akbarabadi and Hazrat Rasoul Akram, of Tehran, Iran, from December 2019 to October 2020. Patients were randomly allocated to the two groups of interventions by a simple randomization method. The proportion of amenorrhea (as primary outcome) and consequent hysterectomy and patient satisfaction (as secondary outcomes) was assessed using the Chi-square test and independent t test. There was no significant difference between the two groups in the baseline characteristics. The percentage of intervention failure was statistically higher in the hysteroscopy group (24%) in comparison with the Cavaterm group [8.2%, P=0.03, relative risk (RR)=1.63, 95% confidence interval (CI): 1.13-2.36]. Mean ± standard deviation of satisfaction based on the Likert score in the Cavaterm group and hysteroscopy group were 4.3 ± 1.21 and 3.7 ± 1.56, respectively, that showed a significant difference (P=0.04). Assessing the procedural complications, the rate of spotting, bloody discharge, and malodor discharge was significantly higher in the Cavaterm group. In contrast, postoperative dysmenorrhea is more common in the hysteroscopy group. Cavaterm ablation is accompanied by a higher success rate of amenorrhea and patients' satisfaction than hysteroscopy ablation (registration number: IRCT20220210053986N1).

Sections du résumé

BACKGROUND BACKGROUND
Abnormal uterine bleeding (AUB) that is any irregularity in menstrual cycles causes women to refer to clinics. This study aimed to compare the efficacy, safety, and complications of endometrial ablation by the thermal balloon (Cavaterm) method with the hysteroscopy loop resection method in the treatment of AUB.
MATERIALS AND METHODS METHODS
The present study is an open-label, randomized clinical trial that was performed in the two hospitals, Shahid Akbarabadi and Hazrat Rasoul Akram, of Tehran, Iran, from December 2019 to October 2020. Patients were randomly allocated to the two groups of interventions by a simple randomization method. The proportion of amenorrhea (as primary outcome) and consequent hysterectomy and patient satisfaction (as secondary outcomes) was assessed using the Chi-square test and independent t test.
RESULTS RESULTS
There was no significant difference between the two groups in the baseline characteristics. The percentage of intervention failure was statistically higher in the hysteroscopy group (24%) in comparison with the Cavaterm group [8.2%, P=0.03, relative risk (RR)=1.63, 95% confidence interval (CI): 1.13-2.36]. Mean ± standard deviation of satisfaction based on the Likert score in the Cavaterm group and hysteroscopy group were 4.3 ± 1.21 and 3.7 ± 1.56, respectively, that showed a significant difference (P=0.04). Assessing the procedural complications, the rate of spotting, bloody discharge, and malodor discharge was significantly higher in the Cavaterm group. In contrast, postoperative dysmenorrhea is more common in the hysteroscopy group.
CONCLUSION CONCLUSIONS
Cavaterm ablation is accompanied by a higher success rate of amenorrhea and patients' satisfaction than hysteroscopy ablation (registration number: IRCT20220210053986N1).

Identifiants

pubmed: 36906831
doi: 10.22074/ijfs.2022.550429.1275
pmc: PMC10009513
pii:
doi:

Banques de données

IRCT
['IRCT20220210053986N1']

Types de publication

Journal Article

Langues

eng

Pagination

133-139

Références

JSLS. 2014 Jul-Sep;18(3):
pubmed: 25392642
BJOG. 2004 Oct;111(10):1095-102
pubmed: 15383112
Mayo Clin Proc. 2019 Feb;94(2):326-335
pubmed: 30711128
J Minim Invasive Gynecol. 2018 Feb;25(2):299-307
pubmed: 28888699
J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1225-30
pubmed: 26149205
Med Arch. 2014 Dec;68(6):411-3
pubmed: 25648851
J Minim Invasive Gynecol. 2006 Sep-Oct;13(5):424-30
pubmed: 16962526
J Minim Invasive Gynecol. 2013 Jul-Aug;20(4):487-91
pubmed: 23870238
Surg Technol Int. 2018 Jun 1;32:129-138
pubmed: 29689590
Obstet Gynecol. 2013 Jul;122(1):176-185
pubmed: 23787936
J Turk Ger Gynecol Assoc. 2019 Sep 09;21(1):1-9
pubmed: 31496211
BJOG. 2008 Jan;115(2):193-8
pubmed: 17617188
Obstet Gynecol. 2014 Aug;124(2 Pt 1):219-225
pubmed: 25004347
Fertil Steril. 2003 Jul;80(1):203-8
pubmed: 12849825
Cochrane Database Syst Rev. 2013 Aug 30;(8):CD001501
pubmed: 23990373

Auteurs

Mahdiss Mohamadianamir (M)

Shahid Akbarabadi, Clinical Research Development Unit (ShACRDU), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Arash Mohazzab (A)

School of Public Health, Iran University of Medical Sciences, Tehran, Iran.

Samaneh Rokhgire (S)

Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.

Zeinab Mansouri (Z)

Department of Obstetrics and Gynecology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Maryam Yazdizadeh (M)

Shahid Akbarabadi, Clinical Research Development Unit (ShACRDU), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Shima Ghezelbash (S)

Shahid Akbarabadi, Clinical Research Development Unit (ShACRDU), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Majid Aklamli (M)

Shahid Akbarabadi, Clinical Research Development Unit (ShACRDU), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Sepideh Azizi (S)

Shahid Akbarabadi, Clinical Research Development Unit (ShACRDU), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Classifications MeSH